About this trial
Single-center randomized trial in patients with pacing indication (AV block) after TAVI (transfemoral aortic valve implantation) and LVEF\> 50%, that aims to study the percentage of patients who improve at 12 months in a combined clinical endpoint.
Eligibility criteria
Qualifiers
Successful implantation of TAVI according to VARC-3 criteria.
Indication of cardiac pacing due to AV block according to ESC Guidelines.
LVEF> 50%.
The patient must indicate their acceptance to participate in the study by signing an informed consent document.
Disqualifiers
Ventricular dysfunction: LVEF <50%.
Transapical TAVI.
Participating currently in a clinical investigation that includes an active treatment.
Patients with left bundle branch block but without indication of pacing (AV block).
Trial design
Treatments tested in this trial
- Conduction system pacing
- Right ventricular pacing
Treatment groups
Locations
1Sponsors and collaborators
Hospital Clinic of Barcelona
Lead sponsor